BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20025598)

  • 1. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
    Nagaraju R; Meera DS; Kaza R; Arvind VV; Venkateswarlu V
    Curr Drug Discov Technol; 2009 Dec; 6(4):299-305. PubMed ID: 20025598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
    Li L; Sun H; Gao J; Jiang T; Gao Y; Zhang J
    Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development of metoprolol succinate and hydrochlorothiazide compression coated tablets.
    Shah R; Parmar S; Patel H; Pandey S; Shah D
    Curr Drug Deliv; 2013 Dec; 10(6):631-44. PubMed ID: 23017092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum.
    Gohel MC; Parikh RK; Nagori SA; Jena DG
    AAPS PharmSciTech; 2009; 10(1):62-8. PubMed ID: 19148762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
    Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
    AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets.
    Amaral MH; Lobo JM; Ferreira DC
    AAPS PharmSciTech; 2001 Apr; 2(2):E6. PubMed ID: 14727881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
    Dadarwal SC; Madan S; Agrawal SS
    Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets.
    Varshosaz J; Tavakoli N; Eram SA
    Drug Deliv; 2006; 13(2):113-9. PubMed ID: 16423799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of splitting on dissolution properties of metoprolol tablets.
    Vranić E; Uzunović A
    Bosn J Basic Med Sci; 2009 Aug; 9(3):245-9. PubMed ID: 19754482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.
    Patere SN; Desai NS; Jain AS; Kadam PP; Thatte UM; Gogtay N; Kapadia CJ; Farah N; Nagarsenker MS
    Curr Drug Deliv; 2013 Oct; 10(5):548-56. PubMed ID: 23607649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design.
    Duque MD; Kreidel RN; Taqueda ME; Baby AR; Kaneko TM; Velasco MV; Consiglieri VO
    Pharm Dev Technol; 2013; 18(5):1247-54. PubMed ID: 22670808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.
    Nair A; Gupta R; Vasanti S
    Pharm Dev Technol; 2007; 12(6):621-5. PubMed ID: 18161635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Badam gum: a natural polymer in mucoadhesive drug delivery. Design, optimization, and biopharmaceutical evaluation of badam gum-based metoprolol succinate buccoadhesive tablets.
    Mylangam CK; Beeravelli S; Medikonda J; Pidaparthi JS; Kolapalli VR
    Drug Deliv; 2016; 23(1):195-206. PubMed ID: 24825493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
    Siddique S; Bose A; Khanam J
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.